Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mackenzie Henderson"'
Autor:
Keyu Li, Junke Wang, Rui Zhang, Jiawei Zhou, Birginia Espinoza, Nan Niu, Jianxin Wang, Noelle Jurcak, Noah Rozich, Arsen Osipov, MacKenzie Henderson, Vanessa Funes, Melissa Lyman, Alex B. Blair, Brian Herbst, Mengni He, Jialong Yuan, Diego Trafton, Chunhui Yuan, Michael Wichroski, Xubao Liu, Juan Fu, Lei Zheng
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-6 (2024)
Abstract Due to the challenge for intratumoral administration, innate agonists have not made it beyond preclinical studies for efficacy testing in most tumor types. Pancreatic ductal adenocarcinoma (PDAC) has a hostile tumor microenvironment that ren
Externí odkaz:
https://doaj.org/article/bfd08d1266be4922922c25e98fb0b353
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundInternational Classification of Diseases, Ninth/Tenth revisions, clinical modification (ICD-9-CM, ICD-10-CM) are frequently used in the U.S. by health insurers and disease registries, and are often recorded in electronic medical records. Du
Externí odkaz:
https://doaj.org/article/2104cf3c0fdf4c0a9109d07827de74a3
Autor:
Kenji Fujiwara, Yingkuan Shao, Nan Niu, Tengyi Zhang, Brian Herbst, Mackenzie Henderson, Stephen Muth, Pingbo Zhang, Lei Zheng
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-5 (2022)
Abstract Background Identifying T cell epitopes on pancreatic ductal adenocarcinoma (PDAC) associated antigens or neoantigens has been a challenge. In this study, we attempted to identify PDAC T cell epitopes by mass spectrometry (MS). Methods We iso
Externí odkaz:
https://doaj.org/article/55e292b387044fd2aed850ced5ae6fdc
Autor:
Michelle D. Hackshaw, Heather E. Danysh, Mackenzie Henderson, Eric Wang, Nora Tu, Zahidul Islam, Amy Ladner, Mary E. Ritchey, Maribel Salas
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background Patients with breast cancer who overexpress the human epidermal growth factor receptor 2 (HER2) and subsequently develop brain metastasis (BM) typically experience poor quality of life and low survival. We conducted a comprehensiv
Externí odkaz:
https://doaj.org/article/b135d65febe64288bf811aadb904d9ae
Autor:
Maribel Salas, Mackenzie Henderson, Meera Sundararajan, Nora Tu, Zahidul Islam, Mina Ebeid, Laura Horne
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252925 (2021)
ObjectiveTo identify comorbidity indices that have been validated in cancer populations, with a focus on breast cancer and human epidermal growth factor receptor-2-positive (HER2+) breast cancer.Study design and settingA systematic review of the lite
Externí odkaz:
https://doaj.org/article/07cd539080644ac4bd6e1fa68efb2d31
Autor:
Maribel Salas, Mackenzie Henderson, Angelika Wientzek-Fleischmann, Zahidul Islam, Nora Tu, Aikaterini Bilitou, Maggie Elsharkawy, Ulf Stellmacher
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
IntroductionAcute myeloid leukemia (AML) can negatively impact quality of life (QOL). Few QOL instruments are specific to and have been validated in AML. This review aims to identify QOL instruments that have been validated in patients with AML and o
Externí odkaz:
https://doaj.org/article/725fada065904ad59a5239f98e26c01d
Publikováno v:
Vaccines, Vol 5, Iss 3, p 25 (2017)
This review aims to evaluate the literature on the safety and efficacy of novel toxoid vaccines for the prophylaxis of Clostridium difficile infections (CDI) in healthy adults. Literature searches for clinical trials were performed through MEDLINE, C
Externí odkaz:
https://doaj.org/article/c8806dc12e3b42059ac3a50d052c448a
Publikováno v:
Cancer Research. 83:P4-07
Background. In the last five years, several new drugs have been approved for BC in the United States, many of which target HER2, including neratinib, margetuximab, tucatinib, and trastuzumab deruxtecan. These approvals depend on a drug’s benefits o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28bba37075e62cb75e8b9c010d00fef3
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-53
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-53
Autor:
Annette Stemhagen, Youngsook Choi, Nora Tu, Zahid Islam, Natalie O'Donnell, Michele Julian, Maribel Salas, Mackenzie Henderson
Publikováno v:
Journal of Comparative Effectiveness Research. 10:953-967
Aim: Pexidartinib was approved for the treatment of tenosynovial giant cell tumors with a required Risk Evaluation and Mitigation Strategy (REMS) to ensure its safe use. As required by the REMS, a survey was conducted to document the knowledge, attit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc1767be29cdc1480e6f472abfe14e4
https://doi.org/10.2217/cer-2020-0253
https://doi.org/10.2217/cer-2020-0253
Autor:
Eric Wang, Mary E Ritchey, Mackenzie Henderson, Maribel Salas, Nora Tu, Michelle D Hackshaw, Zahidul Islam, Amy Ladner, Heather E. Danysh
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
BMC Cancer
BMC Cancer
BackgroundPatients with breast cancer who overexpress the human epidermal growth factor receptor 2 (HER2) and subsequently develop brain metastasis (BM) typically experience poor quality of life and low survival. We conducted a comprehensive literatu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b44bed9642d599fc20c7242b9f8cb0
https://doaj.org/article/b135d65febe64288bf811aadb904d9ae
https://doaj.org/article/b135d65febe64288bf811aadb904d9ae